MSF welcomes GSK's decision to lower the price of the pneumonia vaccine for some of the world's most vulnerable children.
On September 20th, 2016 Médecins Sans Frontiéres/Doctors without Borders (MSF) welcomed the decision by GlaxoSmithKline (GSK) to lower its price of its pneumococcal conjugate vaccine (PCV) for humanitarian organizations that serve refugee and crisis-affected children.
Read on for the entire announcement here.
Dec 12, 2024
In a recent article, Professor William G. Moseley argues that in order to address Africa's food security problems, African agriculture needs to be de-colonialized. He puts forward agroecology as a... Read more
Nov 24, 2024
Violence against women and girls remains one of the most prevalent and pervasive human rights violations in the world. Globally, almost one in three women have been subjected to physical and/or... Read more
Nov 15, 2024
“A group of governments, multilateral development banks, UN agencies, and some of the world’s largest philanthropic organizations are announcing expanded efforts and increased coordination and... Read more